Free Trial

LivaNova (LIVN) Competitors

LivaNova logo
$55.90 +3.04 (+5.75%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$55.90 0.00 (0.00%)
As of 08/22/2025 05:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LIVN vs. PEN, STVN, IRTC, GKOS, BLCO, TMDX, SLNO, NVST, WRBY, and INSP

Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), Warby Parker (WRBY), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.

LivaNova vs. Its Competitors

LivaNova (NASDAQ:LIVN) and Penumbra (NYSE:PEN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, media sentiment, valuation and risk.

LivaNova has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.4, suggesting that its share price is 60% less volatile than the S&P 500.

In the previous week, Penumbra had 6 more articles in the media than LivaNova. MarketBeat recorded 16 mentions for Penumbra and 10 mentions for LivaNova. LivaNova's average media sentiment score of 1.40 beat Penumbra's score of 1.24 indicating that LivaNova is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LivaNova
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Penumbra
12 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

LivaNova presently has a consensus target price of $59.71, suggesting a potential upside of 6.82%. Penumbra has a consensus target price of $300.47, suggesting a potential upside of 13.52%. Given Penumbra's higher possible upside, analysts clearly believe Penumbra is more favorable than LivaNova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LivaNova
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.00
Penumbra
0 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
2 Strong Buy rating(s)
2.94

97.6% of LivaNova shares are held by institutional investors. Comparatively, 88.9% of Penumbra shares are held by institutional investors. 0.3% of LivaNova shares are held by insiders. Comparatively, 4.2% of Penumbra shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Penumbra has a net margin of 11.54% compared to LivaNova's net margin of -16.13%. LivaNova's return on equity of 14.57% beat Penumbra's return on equity.

Company Net Margins Return on Equity Return on Assets
LivaNova-16.13% 14.57% 6.91%
Penumbra 11.54%11.55%8.76%

LivaNova has higher revenue and earnings than Penumbra. LivaNova is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LivaNova$1.25B2.44$63.23M-$3.89-14.37
Penumbra$1.19B8.64$14.01M$3.7670.39

Summary

Penumbra beats LivaNova on 10 of the 17 factors compared between the two stocks.

Get LivaNova News Delivered to You Automatically

Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LIVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIVN vs. The Competition

MetricLivaNovaMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$3.05B$6.84B$5.75B$9.62B
Dividend YieldN/A1.31%4.40%4.10%
P/E Ratio-14.3727.4531.3626.05
Price / Sales2.4475.39434.71196.83
Price / Cash13.1821.3437.7358.48
Price / Book2.726.889.536.61
Net Income$63.23M$176.42M$3.26B$265.65M
7 Day Performance4.06%1.45%2.12%2.02%
1 Month Performance26.70%-2.71%2.80%-0.32%
1 Year Performance19.96%9.40%30.68%19.06%

LivaNova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LIVN
LivaNova
2.4459 of 5 stars
$55.90
+5.8%
$59.71
+6.8%
+21.4%$3.05B$1.25B-14.372,900News Coverage
Positive News
Analyst Forecast
PEN
Penumbra
4.8117 of 5 stars
$255.35
+0.9%
$300.47
+17.7%
+33.9%$9.87B$1.19B67.914,500Positive News
Insider Trade
STVN
Stevanato Group
2.1495 of 5 stars
€22.50
-0.5%
N/A+20.9%€6.81B€1.19B41.675,521Gap Down
IRTC
iRhythm Technologies
1.3222 of 5 stars
$157.93
-1.7%
$157.30
-0.4%
+142.2%$5.16B$591.84M-53.902,000News Coverage
Analyst Forecast
Insider Trade
GKOS
Glaukos
4.7266 of 5 stars
$89.47
-0.4%
$127.42
+42.4%
-27.6%$5.15B$383.48M-54.22780Analyst Revision
BLCO
Bausch + Lomb
1.6965 of 5 stars
$14.49
-0.4%
$15.56
+7.4%
-6.7%$5.15B$4.79B-18.5713,500
TMDX
TransMedics Group
2.8397 of 5 stars
$125.65
-1.5%
$123.00
-2.1%
-30.9%$4.35B$441.54M65.10210News Coverage
Positive News
SLNO
Soleno Therapeutics
4.5685 of 5 stars
$68.09
-4.9%
$114.30
+67.9%
+41.1%$3.81BN/A-16.4530News Coverage
Analyst Forecast
Analyst Revision
NVST
Envista
3.8405 of 5 stars
$20.75
+0.5%
$20.92
+0.9%
+20.6%$3.43B$2.51B64.8312,300
WRBY
Warby Parker
2.2746 of 5 stars
$27.38
+0.9%
$24.06
-12.1%
+94.9%$2.85B$771.32M-391.093,780Analyst Upgrade
INSP
Inspire Medical Systems
4.9386 of 5 stars
$88.28
+0.6%
$165.62
+87.6%
-48.6%$2.60B$802.80M51.031,246News Coverage
Positive News
Short Interest ↓

Related Companies and Tools


This page (NASDAQ:LIVN) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners